SCHEMBL6444106

SCHEMBL6444106

[CH2]C(O)N=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13840481 0.70
SCHEMBL5579285 0.67
SCHEMBL10554952 0.67
SCHEMBL1828811 0.65
SCHEMBL1497948 0.64
SCHEMBL15214291 0.64
SCHEMBL10686131 0.64
SCHEMBL5663048 0.64
SCHEMBL538180 0.64
SCHEMBL9067092 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2480075-B1 COMPOSITIONS AND METHODS FOR INDUCING OR ENHANCING CONNECTIVE TISSUE REPAIR GLENPHARMA AB (SE) 2020-07-01 EP claimed
CN-105765046-A Cleaning composition with rapid foam collapse 罗门哈斯公司 2016-07-13 CN disclosed
EP-1575643-A2 DIRECTLY INJECTABLE FORMULATIONS WHICH PROVIDE ENHANCED CRYOPROTECTION OF CELL PRODUCTS CELL GENESYS, INC. (US) 2005-09-21 EP disclosed
WO-2004058323-A3 DIRECTLY INJECTABLE FORMULATIONS WHICH PROVIDE ENHANCED CRYOPROTECTION OF CELL PRODUCTS CELL GENESYS INC (US) 2004-08-19 WO disclosed
WO-2004058323-A2 DIRECTLY INJECTABLE FORMULATIONS WHICH PROVIDE ENHANCED CRYOPROTECTION OF CELL PRODUCTS CELL GENESYS, INC. (US) 2004-07-15 WO disclosed